78
Participants
Start Date
December 31, 2007
Primary Completion Date
January 31, 2015
Study Completion Date
January 31, 2015
rucaparib (CO-338; formally AG-014699 or PF-01367338)
protein expression analysis
western blotting
immunohistochemistry staining method
liquid chromatography
mass spectrometry
pharmacological study
Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham
Leeds Cancer Centre at St. James's University Hospital, Leeds
Cancer Research UK and University College London Cancer Trials Centre, London
Christie Hospital, Manchester
Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Level 2, Freeman Hospital, Newcastle upon Tyne
Derriford Hospital, Plymouth
Beatson West of Scotland Cancer Centre, Glasgow
Lead Sponsor
Cancer Research UK
OTHER